nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—autistic disorder	0.651	1	CbGaD
Aminosalicylic Acid—CHUK—digestive system—autistic disorder	0.00504	0.0841	CbGeAlD
Aminosalicylic Acid—CHUK—head—autistic disorder	0.00411	0.0686	CbGeAlD
Aminosalicylic Acid—CHUK—cerebellum—autistic disorder	0.00367	0.0612	CbGeAlD
Aminosalicylic Acid—MPO—forebrain—autistic disorder	0.00342	0.0571	CbGeAlD
Aminosalicylic Acid—Methyldopa—COMT—autistic disorder	0.00323	0.361	CrCbGaD
Aminosalicylic Acid—CHUK—brain—autistic disorder	0.00298	0.0497	CbGeAlD
Aminosalicylic Acid—ALOX5—digestive system—autistic disorder	0.00284	0.0474	CbGeAlD
Aminosalicylic Acid—PTGS2—mouth—autistic disorder	0.00246	0.0411	CbGeAlD
Aminosalicylic Acid—MPO—digestive system—autistic disorder	0.0024	0.0401	CbGeAlD
Aminosalicylic Acid—ALOX5—head—autistic disorder	0.00232	0.0386	CbGeAlD
Aminosalicylic Acid—ALOX5—nervous system—autistic disorder	0.00219	0.0366	CbGeAlD
Aminosalicylic Acid—ALOX5—central nervous system—autistic disorder	0.00211	0.0353	CbGeAlD
Aminosalicylic Acid—ALOX5—cerebellum—autistic disorder	0.00207	0.0345	CbGeAlD
Aminosalicylic Acid—MPO—head—autistic disorder	0.00196	0.0327	CbGeAlD
Aminosalicylic Acid—MPO—nervous system—autistic disorder	0.00186	0.031	CbGeAlD
Aminosalicylic Acid—MPO—central nervous system—autistic disorder	0.00179	0.0298	CbGeAlD
Aminosalicylic Acid—ALOX5—brain—autistic disorder	0.00168	0.028	CbGeAlD
Aminosalicylic Acid—PTGS1—forebrain—autistic disorder	0.00162	0.0271	CbGeAlD
Aminosalicylic Acid—PTGS2—forebrain—autistic disorder	0.00155	0.0259	CbGeAlD
Aminosalicylic Acid—PTGS1—telencephalon—autistic disorder	0.00149	0.0249	CbGeAlD
Aminosalicylic Acid—PTGS2—telencephalon—autistic disorder	0.00143	0.0238	CbGeAlD
Aminosalicylic Acid—MPO—brain—autistic disorder	0.00142	0.0237	CbGeAlD
Aminosalicylic Acid—L-DOPA—DRD3—autistic disorder	0.00119	0.132	CrCbGaD
Aminosalicylic Acid—L-DOPA—DRD1—autistic disorder	0.00116	0.13	CrCbGaD
Aminosalicylic Acid—PTGS1—digestive system—autistic disorder	0.00114	0.019	CbGeAlD
Aminosalicylic Acid—PTGS2—digestive system—autistic disorder	0.00109	0.0182	CbGeAlD
Aminosalicylic Acid—Droxidopa—ADRB2—autistic disorder	0.00108	0.121	CrCbGaD
Aminosalicylic Acid—Diflunisal—PTGS2—autistic disorder	0.000979	0.109	CrCbGaD
Aminosalicylic Acid—PTGS1—head—autistic disorder	0.000929	0.0155	CbGeAlD
Aminosalicylic Acid—PTGS2—head—autistic disorder	0.000888	0.0148	CbGeAlD
Aminosalicylic Acid—PTGS1—nervous system—autistic disorder	0.000881	0.0147	CbGeAlD
Aminosalicylic Acid—PTGS1—central nervous system—autistic disorder	0.000848	0.0142	CbGeAlD
Aminosalicylic Acid—PTGS2—nervous system—autistic disorder	0.000842	0.0141	CbGeAlD
Aminosalicylic Acid—PTGS2—central nervous system—autistic disorder	0.000811	0.0135	CbGeAlD
Aminosalicylic Acid—PTGS2—cerebellum—autistic disorder	0.000792	0.0132	CbGeAlD
Aminosalicylic Acid—Mesalazine—PTGS2—autistic disorder	0.000768	0.0857	CrCbGaD
Aminosalicylic Acid—PTGS1—brain—autistic disorder	0.000673	0.0112	CbGeAlD
Aminosalicylic Acid—PTGS2—brain—autistic disorder	0.000644	0.0107	CbGeAlD
Aminosalicylic Acid—Salicylic acid—PTGS2—autistic disorder	0.000544	0.0608	CrCbGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR1D—autistic disorder	9.1e-05	0.000325	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL6—autistic disorder	9.05e-05	0.000323	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—autistic disorder	8.94e-05	0.00032	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—IL6—autistic disorder	8.94e-05	0.00032	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—HRAS—autistic disorder	8.94e-05	0.00032	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC25A12—autistic disorder	8.87e-05	0.000317	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DAO—autistic disorder	8.87e-05	0.000317	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—HRAS—autistic disorder	8.8e-05	0.000315	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—autistic disorder	8.79e-05	0.000314	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRLR—autistic disorder	8.76e-05	0.000313	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC19A1—autistic disorder	8.63e-05	0.000309	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP19A1—autistic disorder	8.6e-05	0.000307	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—MAPK1—autistic disorder	8.59e-05	0.000307	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—autistic disorder	8.56e-05	0.000306	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—UPB1—autistic disorder	8.5e-05	0.000304	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GRM8—autistic disorder	8.46e-05	0.000302	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—autistic disorder	8.42e-05	0.000301	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—HRAS—autistic disorder	8.4e-05	0.0003	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HRAS—autistic disorder	8.38e-05	0.0003	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	8.37e-05	0.000299	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—HRAS—autistic disorder	8.36e-05	0.000299	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—HRAS—autistic disorder	8.32e-05	0.000298	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—HRAS—autistic disorder	8.28e-05	0.000296	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—WNT2—autistic disorder	8.19e-05	0.000293	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—autistic disorder	8.16e-05	0.000292	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PTEN—autistic disorder	8.13e-05	0.000291	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ADSL—autistic disorder	8.12e-05	0.00029	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	8.07e-05	0.000289	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GHR—autistic disorder	8.07e-05	0.000289	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—autistic disorder	8.04e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	8.03e-05	0.000287	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—autistic disorder	8e-05	0.000286	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—COMT—autistic disorder	7.99e-05	0.000286	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-A—autistic disorder	7.98e-05	0.000285	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—autistic disorder	7.96e-05	0.000285	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—XDH—autistic disorder	7.96e-05	0.000285	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTP1—autistic disorder	7.95e-05	0.000284	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDE4A—autistic disorder	7.95e-05	0.000284	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MAPK1—autistic disorder	7.95e-05	0.000284	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MAOA—autistic disorder	7.93e-05	0.000284	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TSC2—autistic disorder	7.93e-05	0.000284	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—autistic disorder	7.92e-05	0.000283	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM5—autistic disorder	7.91e-05	0.000283	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ASMT—autistic disorder	7.91e-05	0.000283	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—STX1A—autistic disorder	7.81e-05	0.000279	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NPAS2—autistic disorder	7.81e-05	0.000279	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—HRAS—autistic disorder	7.79e-05	0.000279	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—autistic disorder	7.79e-05	0.000279	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—HRAS—autistic disorder	7.79e-05	0.000279	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CAT—autistic disorder	7.74e-05	0.000277	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—autistic disorder	7.72e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—HRAS—autistic disorder	7.72e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1RN—autistic disorder	7.68e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—HRAS—autistic disorder	7.65e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—HRAS—autistic disorder	7.62e-05	0.000272	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—DHFR—autistic disorder	7.62e-05	0.000272	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—TSC2—autistic disorder	7.61e-05	0.000272	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TCN2—autistic disorder	7.55e-05	0.00027	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL5—autistic disorder	7.51e-05	0.000269	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—autistic disorder	7.46e-05	0.000267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—autistic disorder	7.46e-05	0.000267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—autistic disorder	7.46e-05	0.000267	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AVPR1A—autistic disorder	7.45e-05	0.000266	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC25A12—autistic disorder	7.43e-05	0.000266	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STX1A—autistic disorder	7.41e-05	0.000265	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—autistic disorder	7.39e-05	0.000264	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—autistic disorder	7.32e-05	0.000262	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTM1—autistic disorder	7.31e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PLA2G4A—autistic disorder	7.31e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DRB1—autistic disorder	7.29e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—autistic disorder	7.29e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC19A1—autistic disorder	7.23e-05	0.000259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—HRAS—autistic disorder	7.21e-05	0.000258	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ADA—autistic disorder	7.2e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GRM5—autistic disorder	7.19e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VIP—autistic disorder	7.19e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ITGA4—autistic disorder	7.17e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TCN2—autistic disorder	7.15e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	7.12e-05	0.000254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PRKCB—autistic disorder	7.03e-05	0.000251	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GPX1—autistic disorder	7e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—OXTR—autistic disorder	6.96e-05	0.000249	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—WNT2—autistic disorder	6.93e-05	0.000248	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGF—autistic disorder	6.92e-05	0.000248	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—autistic disorder	6.9e-05	0.000247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SCT—autistic disorder	6.89e-05	0.000247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CALCA—autistic disorder	6.85e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	6.81e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—MAPK1—autistic disorder	6.72e-05	0.00024	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	6.65e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGF—autistic disorder	6.65e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	6.64e-05	0.000238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MAPK1—autistic disorder	6.61e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—autistic disorder	6.6e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GABBR1—autistic disorder	6.58e-05	0.000235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADM—autistic disorder	6.58e-05	0.000235	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—RORA—autistic disorder	6.57e-05	0.000235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRL—autistic disorder	6.55e-05	0.000234	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EIF4E—autistic disorder	6.46e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—autistic disorder	6.46e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ADSL—autistic disorder	6.44e-05	0.00023	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDE4B—autistic disorder	6.41e-05	0.000229	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—XDH—autistic disorder	6.32e-05	0.000226	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—OPRM1—autistic disorder	6.21e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—STX1A—autistic disorder	6.2e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NPAS2—autistic disorder	6.2e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MAOB—autistic disorder	6.15e-05	0.00022	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—autistic disorder	6.11e-05	0.000218	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PRL—autistic disorder	6.05e-05	0.000216	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—autistic disorder	6.01e-05	0.000215	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TCN2—autistic disorder	5.99e-05	0.000214	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	5.86e-05	0.000209	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TPH2—autistic disorder	5.72e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RPL10—autistic disorder	5.72e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ADA—autistic disorder	5.72e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GZMB—autistic disorder	5.68e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	5.65e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—DPYD—autistic disorder	5.63e-05	0.000201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—BCL2—autistic disorder	5.6e-05	0.0002	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR1B—autistic disorder	5.51e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—OXT—autistic disorder	5.51e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3CG—autistic disorder	5.43e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	5.41e-05	0.000193	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	5.41e-05	0.000193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HRAS—autistic disorder	5.4e-05	0.000193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MEF2C—autistic disorder	5.34e-05	0.000191	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HRAS—autistic disorder	5.31e-05	0.00019	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	5.28e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CACNA1C—autistic disorder	5.23e-05	0.000187	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—RORA—autistic disorder	5.21e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—POMC—autistic disorder	5.17e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—autistic disorder	5.17e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DRD1—autistic disorder	5.12e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TSC1—autistic disorder	5.12e-05	0.000183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—autistic disorder	5.08e-05	0.000182	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	5.03e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NTRK2—autistic disorder	4.98e-05	0.000178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DRD3—autistic disorder	4.96e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MAOB—autistic disorder	4.88e-05	0.000175	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL5—autistic disorder	4.86e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-A—autistic disorder	4.84e-05	0.000173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CALCA—autistic disorder	4.8e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—DHFR—autistic disorder	4.76e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	4.65e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PTEN—autistic disorder	4.64e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TSC2—autistic disorder	4.62e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TPH2—autistic disorder	4.54e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—DHFR—autistic disorder	4.51e-05	0.000161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—autistic disorder	4.48e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HLA-A—autistic disorder	4.47e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DPYD—autistic disorder	4.47e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTEN—autistic disorder	4.45e-05	0.000159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRB1—autistic disorder	4.42e-05	0.000158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TSC2—autistic disorder	4.26e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRKCB—autistic disorder	4.26e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRL—autistic disorder	4.24e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	4.19e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—autistic disorder	4.17e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CACNA1C—autistic disorder	4.15e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—autistic disorder	4.12e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CALCA—autistic disorder	4.06e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGF—autistic disorder	4.03e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADRB2—autistic disorder	4.02e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	4.01e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	3.99e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—autistic disorder	3.89e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—DHFR—autistic disorder	3.78e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AVP—autistic disorder	3.78e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK1—autistic disorder	3.77e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APC—autistic disorder	3.77e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF2—autistic disorder	3.76e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP19A1—autistic disorder	3.73e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGF—autistic disorder	3.72e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—autistic disorder	3.59e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRL—autistic disorder	3.58e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLA2G4A—autistic disorder	3.55e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.5e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—COMT—autistic disorder	3.47e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MEF2C—autistic disorder	3.45e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTP1—autistic disorder	3.45e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MAOA—autistic disorder	3.44e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ITGB3—autistic disorder	3.37e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAT—autistic disorder	3.36e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SERPINE1—autistic disorder	3.27e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—autistic disorder	3.26e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—autistic disorder	3.23e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—autistic disorder	3.17e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLA2G4A—autistic disorder	3.17e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR2A—autistic disorder	3.14e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—autistic disorder	3.03e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HRAS—autistic disorder	3.03e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TSC2—autistic disorder	2.99e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP19A1—autistic disorder	2.96e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—autistic disorder	2.92e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—autistic disorder	2.92e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HRAS—autistic disorder	2.91e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—autistic disorder	2.9e-05	0.000104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—autistic disorder	2.87e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—autistic disorder	2.86e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—autistic disorder	2.8e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.78e-05	9.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCB—autistic disorder	2.76e-05	9.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—COMT—autistic disorder	2.75e-05	9.84e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTP1—autistic disorder	2.74e-05	9.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MAOA—autistic disorder	2.73e-05	9.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—autistic disorder	2.7e-05	9.66e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAT—autistic disorder	2.66e-05	9.53e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—autistic disorder	2.65e-05	9.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HLA-A—autistic disorder	2.65e-05	9.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3CG—autistic disorder	2.64e-05	9.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APC—autistic disorder	2.64e-05	9.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—autistic disorder	2.61e-05	9.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGF—autistic disorder	2.61e-05	9.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TSC2—autistic disorder	2.53e-05	9.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLA2G4A—autistic disorder	2.52e-05	9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—autistic disorder	2.52e-05	9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—POMC—autistic disorder	2.51e-05	8.98e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—autistic disorder	2.49e-05	8.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—autistic disorder	2.47e-05	8.84e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—autistic disorder	2.41e-05	8.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—autistic disorder	2.41e-05	8.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3CG—autistic disorder	2.35e-05	8.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—autistic disorder	2.3e-05	8.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SERPINE1—autistic disorder	2.29e-05	8.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—POMC—autistic disorder	2.24e-05	8.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APC—autistic disorder	2.23e-05	7.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—autistic disorder	2.22e-05	7.95e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGF—autistic disorder	2.2e-05	7.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK1—autistic disorder	2.2e-05	7.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—autistic disorder	2.07e-05	7.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MAPK1—autistic disorder	2.03e-05	7.25e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SERPINE1—autistic disorder	1.94e-05	6.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3CG—autistic disorder	1.87e-05	6.68e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—autistic disorder	1.86e-05	6.64e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—autistic disorder	1.79e-05	6.39e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—POMC—autistic disorder	1.78e-05	6.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HRAS—autistic disorder	1.76e-05	6.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—autistic disorder	1.75e-05	6.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—autistic disorder	1.69e-05	6.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HRAS—autistic disorder	1.63e-05	5.82e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—autistic disorder	1.56e-05	5.57e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—autistic disorder	1.56e-05	5.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—autistic disorder	1.48e-05	5.28e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK1—autistic disorder	1.42e-05	5.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—autistic disorder	1.24e-05	4.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MAPK1—autistic disorder	1.2e-05	4.29e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HRAS—autistic disorder	1.14e-05	4.08e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—autistic disorder	1.09e-05	3.9e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HRAS—autistic disorder	9.64e-06	3.45e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—autistic disorder	9.23e-06	3.3e-05	CbGpPWpGaD
